Frontlight ResearchEarly access
Acute myeloid leukaemia trials in United States
334 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 2/3Taking peopleA Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)
- Where
- Atlanta, Duarte, Houston, St Louis, Tampa, The Bronx
- Age
- 18 years and over
- People
- 660 worldwide
- Run by
- AbbVie
See details and how to joinNCT07581002 · EU 2025-523724-47-00 - No phaseNot yet taking people in United StatesPrevention of Oral Mucositis in Adults in With Hematologic Malignancy
- Where
- Milwaukee, Oak Lawn, Park Ridge
- Age
- 18 years and over
- People
- 206
- Run by
- Wake Forest University Health Sciences
See details and how to joinNCT07809984 - No phaseEnrolling by invitationBiology Studies of Hematologic Cancers
- Where
- Bethesda
- Age
- 1 year to 120 years
- People
- 550
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT00923442 - Phase 1Taking peopleCER-1236 in Patients With Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), and Myelofibrosis (MF)
- Where
- Denver, Houston, Nashville, Sacramento, Seattle
- Age
- 18 years to 85 years
- People
- 18
- Run by
- CERo Therapeutics Holdings, Inc.
See details and how to joinNCT06834282 - Phase 3Taking peopleStudy of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
- Where
- Chapel Hill, Duarte, Farmington, Goodyear, Greenville, Houston, Indianapolis, Morristown, Providence, Shreveport, Tampa
- Age
- 12 years and over
- People
- 468 worldwide
- Run by
- Syndax Pharmaceuticals
See details and how to joinNCT07211958 · EU 2025-522279-27-00 - Phase 2Taking peopleGraft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)
- Where
- Pittsburgh, Seattle, Tampa
- Age
- 1 year to 60 years
- People
- 120
- Run by
- Fred Hutchinson Cancer Center
See details and how to joinNCT03970096 - No phaseTaking peopleBrain MRF in Children, Adolescents and Young Adults With Acute Leukemia
- Where
- Cleveland
- Age
- Up to 30 years
- People
- 20
- Run by
- Case Comprehensive Cancer Center
See details and how to joinNCT06421155 - Phase 1Taking peopleEganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML/HR-MDS and in Combination With Azacitidine in Previously Untreated HR-MDS
- Where
- Aurora, Boston, Cleveland, Columbus, Duarte, Houston, New York, St Louis, Tampa
- Age
- 18 years and over
- People
- 105 worldwide
- Run by
- Stelexis BioSciences
See details and how to joinNCT06533761 · EU 2024-518071-58-00 - Phase 1Taking peopleOlutasidenib for the Treatment of Patients With IDH1 Mutated AML, MDS or CMML After Donor Hematopoietic Cell Transplant
- Where
- Cleveland, Duarte
- Age
- 18 years and over
- People
- 15
- Run by
- City of Hope Medical Center
See details and how to joinNCT06543381 - Phase 2Taking peopleInduction and Consolidation With Fludarabine, Cytarabine, Idarubicin, and Venetoclax for the Treatment of Acute Myeloid Leukemia
- Where
- Portland
- Age
- 18 years to 65 years
- People
- 102
- Run by
- OHSU Knight Cancer Institute
See details and how to joinNCT07228273 - Phase 1Taking peopleCD64 CAR T Cell Therapy in Adults With Relapsed and/or Refractory AML
- Where
- Aurora
- Age
- 18 years and over
- People
- 23
- Run by
- University of Colorado, Denver
See details and how to joinNCT07347418 - Phase 1/2Taking peopleA Study of Revumenib and Mezigdomide in People With Leukemia
- Where
- Basking Ridge, Chapel Hill, Commack, Duarte, Harrison, Houston, Middletown, Montvale, New York, Rockville Centre
- Age
- 12 years and over
- People
- 52
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT07356154 - Phase 1Taking peopleRevumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant
- Where
- Duarte
- Age
- 2 years and over
- People
- 27
- Run by
- City of Hope Medical Center
See details and how to joinNCT06575296 - No phaseTaking peopleRandomization for the Identification of Best Treatment Intensity for Less Fit Adults With Acute Myeloid Leukemia and Myeloid Neoplasms
- Where
- Seattle
- Age
- 18 years and over
- People
- 50
- Run by
- Fred Hutchinson Cancer Center
See details and how to joinNCT07094750 - No phaseTaking peopleComprehensive Molecular and Clinical Evaluation of Pediatric and Adult MDS
- Where
- Bethesda
- Age
- 1 day to 120 years
- People
- 1,100
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05350748 - Phase 1Taking peoplePhase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS
- Where
- Buffalo, Chapel Hill, Columbus, Duarte, Houston, Nashville, New York, Philadelphia, Tampa
- Age
- 18 years and over
- People
- 69 worldwide
- Run by
- Auron Therapeutics, Inc.
See details and how to joinNCT06846606 · EU 2025-521394-13-00 - No phaseTaking peopleStudy of Individuals and Families With Aberrations in DDX41 or Similar Cancer Predisposition Variants
- Where
- Bethesda
- Age
- 1 month to 120 years
- People
- 510
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT07019155 - Phase 1Not yet taking people in United StatesAxatilimab Combined With Decitabine/Venetoclax for the Treatment of TP53-mutated AML
- Where
- Atlanta
- Age
- 18 years and over
- People
- 32
- Run by
- Northside Hospital, Inc.
See details and how to joinNCT07511062 - No phaseEnrolling by invitationForecasting Relapse Outcomes With AlloHeme-based Risk Detection in Post-Allo-HCT AML/MDS Patients (FORWARD)
- Where
- Brisbane, San Francisco, St Louis
- Age
- 18 years and over
- People
- 400
- Run by
- CareDx
See details and how to joinNCT07607327 - Phase 1Taking peopleDanvatirsen Monotherapy Followed by Combination With Venetoclax in Relapsed/Refractory MDS & AML
- Where
- Houston, The Bronx
- Age
- 18 years and over
- People
- 38
- Run by
- Montefiore Medical Center
See details and how to joinNCT05986240 - Phase 1Taking peopleNiclosamide in Pediatric Patients With Relapsed and Refractory AML
- Where
- Palo Alto
- Age
- 2 years to 30 years
- People
- 16
- Run by
- Stanford University
See details and how to joinNCT05188170 - Phase 2Taking peopleRuxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome
- Where
- Duarte
- Age
- 2 years to 22 years
- People
- 40
- Run by
- City of Hope Medical Center
See details and how to joinNCT06128070 - Phase 1Taking peoplePET/MRI, 18F-FDG PET/CT and Whole Body MRI in Finding Extramedullary Myeloid Leukemia in Patients With Newly Diagnosed Acute Myeloid Leukemia
- Where
- Houston
- Age
- 18 years and over
- People
- 77
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT02390635 - Phase 2Not yet taking people in United StatesCD34+ Transplants for Myeloid Malignancies
- Where
- Miami
- Age
- 18 years to 70 years
- People
- 50
- Run by
- Guenther Koehne
See details and how to joinNCT05565105 - Phase 2Not yet taking people in United StatesA Pragmatic Clinical Trial to Prevent Relapse for Myeloid Malignancies With Measurable Disease Prior to Allogeneic Transplant
- Where
- Milwaukee
- Age
- 18 years and over
- People
- 450
- Run by
- Medical College of Wisconsin
See details and how to joinNCT07572929